학술논문
A Phase 3, Multicenter, Randomized, Controlled Trial to Evaluate Immune Equivalence and Safety of Multidose and Single-dose Formulations of Vi-DT Typhoid Conjugate Vaccine in Healthy Filipino Individuals 6 Months to 45 Years of Age
Document Type
Article
Author
Carlos, Josefina Cadorna; Tadesse, Birkneh Tilahun; Borja-Tabora, Charissa; Alberto, Edison; Ylade, Michelle C.; Sil, Arijit; Kim, Deok Ryun; Ahn, Hyeon Seon; Yang, Jae Seung; Lee, Ji Yeon; Kim, Min Soo; Park, Jiwook; Kwon, Soo-Young; Kim, Hun; Yang, Seon-Young; Ryu, Ji-hwa; Park, Hokeun; Shin, Jong-hoon; Lee, Yoonyeong; Kim, Jerome H.; Mojares, Zenaida Reynoso; Wartel, T. Anh; Sahastrabuddhe, Sushant
Source
In The Lancet Regional Health - Western Pacific July 2022 24
Subject
Language
ISSN
2666-6065